Elekta adds ultrasound targeting to cancer treatment
This article was originally published in Clinica
Following a worldwide distribution agreement with North American Scientific (NAS), Elekta's line of digital radiation delivery systems for cancer treatment is to boast an additional ultrasound targeting feature for enhanced treatment accuracy.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.